InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Sunday, 06/13/2021 10:04:47 PM

Sunday, June 13, 2021 10:04:47 PM

Post# of 2139
Most undervalued Biotech stock on planet earth! Book it!

In just 28 days at the low dose, HEPA CRV431 results were as good as what Madrigal's P3 lead NASH drug took 12 weeks to accomplish.


June 2021 Hepa Biz Presentation

https://hepionpharma.com/wp-content/uploads/2021/06/Corporate-deck-June-2021-FINAL.pdf

HEPA AI-POWR
https://hepionpharma.com/ai-powr/

Tackling Chronic Liver Disease - CRV431 Mechanism of Action




HEPA GLOBAL NASH CONFERENCE PRESENTATION:



https://12ewye24eigk3g5kwa2dxjzm-wpengine.netdna-ssl.com/wp-content/uploads/2021/04/4thGlobal_NASH_Congress_Draft_20Apr2021_FINAL-1.pdf

HEPA website
https://hepionpharma.com


Nash Phase 2 & 3 Trials by companies in the space:

AKRO Akero Therapeutics 1.1 Billion Marketcap 240 Million in cash
MDGL Madrigal Pharmaceutical 1.7 Billion Marketcap 300 Million in cash

HEPA Hepion Pharmaceuticals 160 Million market cap 120 million in cash


$HEPA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News